NuvaRing Lawsuit 2026: The $100 Million Settlement, Payout Tiers, and Why New Claims Are Nearly Impossible
Quick Answer
- The NuvaRing lawsuit settled for $100 million in 2014, resolving claims that the birth control ring caused dangerous blood clots .
- Approximately 3,800 claimants received compensation, with an average payout of $58,000, but severe injury cases received significantly more .
- No new NuvaRing claims are being accepted as of May 2026. The settlement is fully distributed and the MDL closed in 2022 .
Is the NuvaRing Lawsuit Real and What Was It About?
The NuvaRing lawsuit is real, and it resolved one of the largest pharmaceutical liability cases involving hormonal contraception . Thousands of women filed claims against Merck & Co. and its subsidiary Organon, alleging that the NuvaRing contraceptive device caused dangerous blood clots, pulmonary embolisms, heart attacks, and strokes .
The NuvaRing is a flexible contraceptive ring inserted into the vagina that releases estrogen and progestin. Unlike traditional birth control pills, the ring delivers hormones continuously over three weeks .
The central allegation was that NuvaRing carried a higher risk of venous thromboembolism (VTE) than older oral contraceptives, and that Merck failed to adequately warn patients and doctors about that risk . Independent studies cited in the litigation suggested NuvaRing users were twice as likely to develop blood clots compared to women using oral contraceptives .
Merck denied any wrongdoing as part of the settlement. The company agreed to pay $100 million in February 2014 to resolve all pending and future claims, provided that at least 95% of eligible claimants opted into the program .
How Much Was the NuvaRing Settlement Worth?
The NuvaRing settlement fund was $100 million, covering approximately 3,800 eligible claimants . The settlement was finalized in June 2014 after the 95% participation threshold was reached .
| Settlement Detail | Value |
|---|---|
| Total settlement fund | $100,000,000 |
| Eligible claimants | ~3,800 |
| Average payout | ~$58,000 |
| Administrator | BrownGreer |
| Finalized | June 2014 |
| MDL closed | 2022 |
The $100 million payment was made into a Qualified Settlement Fund on August 31, 2014 . Claims were reviewed by a Plaintiffs’ Claim Review Committee, which allocated funds based on proof of NuvaRing use and documented diagnosis of qualifying injuries .
The average payout of $58,000 sounds substantial, but it masks wide variation. Women with fatal blood clots or permanent disabilities received significantly more. Those with milder injuries that resolved without lasting complications received far less .
How Much Did Each NuvaRing Claimant Actually Receive?
Individual NuvaRing payouts varied dramatically based on injury severity, and the $58,000 average is misleading. Legal fees and costs were deducted from each award, reducing what claimants actually pocketed .
Here is the payout tier breakdown based on injury severity:
| Tier | Injury Type | Estimated Payout Range |
|---|---|---|
| Tier 1 | Fatal blood clot / wrongful death | $75,000 to $200,000+ |
| Tier 2 | Severe injury (stroke, PE with lasting effects) | $30,000 to $100,000 |
| Tier 3 | Moderate injury (DVT with hospitalization) | $10,000 to $40,000 |
| Tier 4 | Mild injury (treatable clot, full recovery) | $5,000 to $15,000 |
Attorney fees typically ran 33% to 40% of the settlement, deducted from each individual’s share . Claimants in the lower tiers sometimes received only a few thousand dollars after fees .
The parents of Erika Langhart, who opted out of the settlement to pursue their own trial, said the compensation offered was $74,000. They called that amount insufficient for someone’s life .
Key Takeaway: The NuvaRing settlement’s $58,000 average payout is misleading. After attorney fees and based on injury severity, some claimants received only a few thousand dollars while severe injury cases received well over $100,000 .
Can You Still File a NuvaRing Claim in 2026?
No, you cannot file a NuvaRing claim in 2026. The settlement is fully distributed, the MDL was closed in 2022, and Drugwatch reports it is unaware of any attorneys currently accepting NuvaRing lawsuits as of May 2026 .
The deadline to submit claims was July 21, 2014 . That deadline was not extended. Anyone who did not opt into the settlement by that date lost the opportunity to participate in the $100 million fund.
A federal panel closed the NuvaRing multidistrict litigation in November 2022 . The last remaining cases were resolved, and no new cases have been filed since.
If you believe you have a late-discovered injury, you would need to pursue an individual lawsuit against Merck outside the settlement. That would require proving your injury was caused by NuvaRing, and you would need to file within your state’s statute of limitations. Most states give you 2 to 3 years from the date of injury or discovery . Given that NuvaRing’s patent expired and generic versions entered the market years ago, and the MDL is closed, new claims face steep practical hurdles.
What Injuries Qualified for the NuvaRing Settlement?
The NuvaRing settlement covered specific blood clot-related injuries that claimants alleged were caused by the contraceptive device. Not every side effect qualified.
Qualifying injuries included :
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Other venous thrombotic events
- Arterial clots
- Superficial thrombophlebitis
Claims could be filed by injured women or by survivors of those who died after using NuvaRing . Wrongful death claims were eligible for higher compensation.
To qualify, claimants needed to provide proof of NuvaRing use and documented diagnosis of one or more qualifying injuries . Medical records and prescription records were required as part of the claim package .
Reality Check: No one texts or emails you in 2026 offering to “release” NuvaRing settlement funds for a fee. The settlement was finalized in 2014 and fully distributed. Any message claiming otherwise is a scam. There is no claim process, no administrator accepting new claims, and no money waiting for you.
Why Did Merck Settle the NuvaRing Lawsuits?
Merck settled to resolve thousands of pending claims after more than five years of litigation and a mixed record in early court rulings. The company faced more than 2,100 lawsuits in state and federal courts .
Reed Smith, Merck’s defense counsel, had tallied a 9-0 record getting bellwether cases thrown out on summary judgment . That defense success might have made trial outcomes uncertain for plaintiffs. But settling eliminated the risk of a massive jury verdict and cleared Merck’s docket.
The settlement was contingent on 95% claimant participation . If more than 5% of eligible claimants rejected the deal, Merck could walk away and take its chances at trial . The threshold was reached, and the settlement was finalized in June 2014 .
Judge Rodney Sippel called the settlement “a fair resolution” . It resolved not only filed lawsuits but also claims that had not yet been filed in court, as long as those claimants had alleged an injury prior to February 7, 2014 .
What Was the NuvaRing MDL and How Did It Work?
The NuvaRing multidistrict litigation (MDL) was established in August 2008 when the Judicial Panel on Multidistrict Litigation consolidated 11 federal lawsuits for coordinated pretrial proceedings . The MDL was assigned to Judge Rodney Sippel in the U.S. District Court for the Eastern District of Missouri .
By December 2010, there were approximately 730 NuvaRing cases, with 610 in the federal MDL and 110 in consolidated discovery proceedings in Bergen County, New Jersey . Those numbers grew to more than 2,100 lawsuits by the time of settlement .
The New Jersey Supreme Court also designated all NuvaRing cases as a “mass tort” in March 2009, assigning them to Judge Brian R. Martinotti in Bergen County . The $100 million settlement resolved cases in both venues .
The MDL mechanism allowed plaintiffs from across the country to pool resources, share discovery, and present a unified front against Merck. Without it, individual plaintiffs would have faced a well-resourced corporate defendant alone.
What Happens Next for NuvaRing Litigation in 2026?
There is no next step for NuvaRing litigation. The case is closed, the settlement is distributed, and the MDL was terminated in 2022 .
Ongoing: No attorneys are accepting NuvaRing lawsuits as of May 2026 .
Closed: The MDL was closed in November 2022 .
Fully Distributed: All settlement funds have been paid to claimants who opted in by July 21, 2014 .
The NuvaRing case is now a historical example of mass tort litigation involving women’s health products. It has been cited in coverage of similar litigation involving Essure, Paragard, and other contraceptives .
Frequently Asked Questions
Is the NuvaRing lawsuit real?
Yes. More than 2,100 lawsuits were filed against Merck alleging NuvaRing caused blood clots. Merck settled all claims for $100 million in 2014 .
How much was the NuvaRing settlement?
The settlement fund was $100 million, covering approximately 3,800 claimants with an average payout of $58,000 before attorney fees .
Can I still file a NuvaRing claim in 2026?
No. The claim deadline was July 21, 2014. The MDL closed in 2022, and no attorneys are accepting NuvaRing lawsuits as of May 2026 .
What injuries qualified for the NuvaRing settlement?
Qualifying injuries included deep vein thrombosis (DVT), pulmonary embolism (PE), other venous thrombotic events, arterial clots, and superficial thrombophlebitis .
How much did individual claimants actually receive?
Payouts ranged from a few thousand dollars for mild injuries to over $200,000 for fatal blood clots. Attorney fees of 33% to 40% were deducted from each share .
Who administered the NuvaRing settlement?
BrownGreer served as the Claims Administrator for the NuvaRing settlement program .
Why did some people opt out of the NuvaRing settlement?
Some claimants, including the parents of Erika Langhart, believed the settlement undervalued their claims and chose to pursue individual trials. The Langharts’ case was dismissed in 2016 .
What was the NuvaRing MDL case number?
The federal NuvaRing MDL was No. 08-md-1964, assigned to Judge Rodney Sippel in the U.S. District Court for the Eastern District of Missouri .
The Bottom Line: A Closed Case With No New Claims
The NuvaRing lawsuit is over. The $100 million settlement was finalized in 2014, distributed to approximately 3,800 claimants, and the MDL was closed in 2022 . If you are searching for a NuvaRing claim in 2026, the verified answer is that none exists.
The average payout was $58,000 before fees, but the actual amounts varied widely based on injury severity . Mild injury cases received only a few thousand dollars after attorney fees. Fatal blood clot cases received significantly more.
If you believe you have a late-discovered injury tied to NuvaRing, consult a mass tort attorney promptly. Statutes of limitations in your state may still apply, but the practical obstacles are substantial.
